LOGGIC/FIREFLY-2: a phase 3, randomized trial of tovorafenib vs. chemotherapy in pediatric and young adult patients with newly diagnosed low-grade glioma harboring an activating RAF alterationCornelis M. van Tilburg, Olaf Witt, Lindsay Kilburn et al.|BMC Cancer|2024Cited by 66
LOGGIC Core BioClinical Data Bank: Added clinical value of RNA-Seq in an international molecular diagnostic registry for pediatric low-grade glioma patientsEmily C. Hardin, Cornelis M. van Tilburg, Simone Schmid et al.|Neuro-Oncology|2023Cited by 28
Infectious exposure in the first years of life and risk of central nervous system tumours in children: analysis of birth order, childcare attendance and seasonality of birthLone Schmidt, Joachim Schüz, Astrid Sehested et al.|British Journal of Cancer|2010Cited by 18
European standard clinical practice recommendations for primary pediatric low-grade gliomasKleoniki Roka, A.Y.N. Schouten-Van Meeteren, Katrin Scheinemann et al.|EJC Paediatric Oncology|2024Cited by 9
Towards a Risk-Based Follow-Up Surveillance Imaging Schedule for Children and Adolescents with Low-Grade GliomaKleoniki Roka, Katrin Scheinemann, Karina J. Kersbergen et al.|Current Oncology|2024Cited by 2